Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 22.94
-1.06 (-4.42%)
At close: Jun 1, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 265.71 million as of June 1, 2026. Its market cap has increased by 86.06% in one year.
Market Cap
265.71M
Enterprise Value
256.79M
Revenue
80.25M
Ranking
n/a
PE Ratio
109.24
Stock Price
22.94
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 265.71M, an increase of 720.13%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 277.99M | 112.68% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resonance Specialties | 1.46B |
| Smruthi Organics | 1.41B |
| Tyche Industries | 1.40B |
| Krebs Biochemicals & Industries | 1.39B |
| Bacil Pharma | 718.08M |
| Vasundhara Rasayans | 473.23M |
| Crestchem | 372.00M |
| Alfavision Overseas (India) | 288.78M |